Sartorius Stedim Biotech S.A. (FRA:56S1)

Germany flag Germany · Delayed Price · Currency is EUR
174.90
+0.90 (0.52%)
Last updated: Jul 24, 2025
0.52%
Market Cap17.12B
Revenue (ttm)2.90B
Net Income (ttm)225.20M
Shares Outn/a
EPS (ttm)2.31
PE Ratio76.00
Forward PE36.06
Dividend0.69 (0.39%)
Ex-Dividend DateApr 2, 2025
Volumen/a
Average Volume351
Open174.90
Previous Close174.00
Day's Range174.90 - 174.90
52-Week Range144.80 - 235.20
Betan/a
RSI28.76
Earnings DateJul 22, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog... [Read more]

Industry Laboratory Analytical Instruments
Founded 1978
Employees 9,901
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 56S1
Full Company Profile

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.

Financial Statements

News

There is no news available yet.